{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T17:45:16Z","timestamp":1787507116241,"version":"build-2736575974"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2017,7,27]],"date-time":"2017-07-27T00:00:00Z","timestamp":1501113600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005633","name":"Syd\u00e4ntutkimuss\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005633","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Epidemiol"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1007\/s10654-017-0285-4","type":"journal-article","created":{"date-parts":[[2017,7,27]],"date-time":"2017-07-27T06:32:00Z","timestamp":1501137120000},"page":"947-959","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Renin-angiotensin system inhibitors and risk of fractures: a prospective cohort study and meta-analysis of published observational cohort studies"],"prefix":"10.1007","volume":"32","author":[{"given":"Setor K.","family":"Kunutsor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley W.","family":"Blom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"Whitehouse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick G.","family":"Kehoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jari A.","family":"Laukkanen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,7,27]]},"reference":[{"issue":"9773","key":"285_CR1","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/S0140-6736(10)62349-5","volume":"377","author":"TD Rachner","year":"2011","unstructured":"Rachner TD, Khosla S, Hofbauer LC. Osteoporosis: now and the future. Lancet. 2011;377(9773):1276\u201387. doi: 10.1016\/S0140-6736(10)62349-5 .","journal-title":"Lancet"},{"issue":"12","key":"285_CR2","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1007\/s00198-008-0634-y","volume":"19","author":"JA Cauley","year":"2008","unstructured":"Cauley JA, Wampler NS, Barnhart JM, et al. Incidence of fractures compared to cardiovascular disease and breast cancer: the Women\u2019s Health Initiative Observational Study. Osteoporos Int. 2008;19(12):1717\u201323. doi: 10.1007\/s00198-008-0634-y .","journal-title":"Osteoporos Int"},{"issue":"12","key":"285_CR3","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1007\/s00198-006-0172-4","volume":"17","author":"O Johnell","year":"2006","unstructured":"Johnell O, Kanis JA. An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int. 2006;17(12):1726\u201333. doi: 10.1007\/s00198-006-0172-4 .","journal-title":"Osteoporos Int"},{"issue":"9","key":"285_CR4","doi-asserted-by":"publisher","first-page":"2727","DOI":"10.1007\/s00198-016-3608-5","volume":"27","author":"K Thorne","year":"2016","unstructured":"Thorne K, Johansen A, Akbari A, Williams JG, Roberts SE. The impact of social deprivation on mortality following hip fracture in England and Wales: a record linkage study. Osteoporos Int. 2016;27(9):2727\u201337. doi: 10.1007\/s00198-016-3608-5 .","journal-title":"Osteoporos Int"},{"issue":"5 Suppl 51","key":"285_CR5","first-page":"S125","volume":"26","author":"GG Teng","year":"2008","unstructured":"Teng GG, Curtis JR, Saag KG. Mortality and osteoporotic fractures: is the link causal, and is it modifiable? Clin Exp Rheumatol. 2008;26(5 Suppl 51):S125\u201337.","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"285_CR6","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.amjhyper.2004.08.016","volume":"18","author":"JL Perez-Castrillon","year":"2005","unstructured":"Perez-Castrillon JL, Martin-Escudero JC, Alvarez Manzanares P, Cortes Sancho R, Iglesias Zamora S, Garcia Alonso M. Hypertension as a risk factor for hip fracture. Am J Hypertens. 2005;18(1):146\u20137. doi: 10.1016\/j.amjhyper.2004.08.016 .","journal-title":"Am J Hypertens"},{"issue":"7","key":"285_CR7","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/jhh.2008.156","volume":"23","author":"J Woo","year":"2009","unstructured":"Woo J, Kwok T, Leung J, Tang N. Dietary intake, blood pressure and osteoporosis. J Hum Hypertens. 2009;23(7):451\u20135. doi: 10.1038\/jhh.2008.156 .","journal-title":"J Hum Hypertens"},{"issue":"7 Pt 1","key":"285_CR8","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/S0895-7061(01)01303-6","volume":"14","author":"K Tsuda","year":"2001","unstructured":"Tsuda K, Nishio I, Masuyama Y. Bone mineral density in women with essential hypertension. Am J Hypertens. 2001;14(7 Pt 1):704\u20137.","journal-title":"Am J Hypertens"},{"issue":"9183","key":"285_CR9","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0140-6736(99)01437-3","volume":"354","author":"FP Cappuccio","year":"1999","unstructured":"Cappuccio FP, Meilahn E, Zmuda JM, Cauley JA. High blood pressure and bone-mineral loss in elderly white women: a prospective study. Study of Osteoporotic Fractures Research Group. Lancet. 1999;354(9183):971\u20135.","journal-title":"Lancet"},{"issue":"3","key":"285_CR10","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1111\/j.1532-5415.2011.03317.x","volume":"59","author":"A Gangavati","year":"2011","unstructured":"Gangavati A, Hajjar I, Quach L, et al. Hypertension, orthostatic hypotension, and the risk of falls in a community-dwelling elderly population: the maintenance of balance, independent living, intellect, and zest in the elderly of Boston study. J Am Geriatr Soc. 2011;59(3):383\u20139. doi: 10.1111\/j.1532-5415.2011.03317.x .","journal-title":"J Am Geriatr Soc"},{"issue":"4","key":"285_CR11","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/00004872-198708000-00010","volume":"5","author":"A Hvarfner","year":"1987","unstructured":"Hvarfner A, Bergstrom R, Morlin C, Wide L, Ljunghall S. Relationships between calcium metabolic indices and blood pressure in patients with essential hypertension as compared with a healthy population. J Hypertens. 1987;5(4):451\u20136.","journal-title":"J Hypertens"},{"issue":"9","key":"285_CR12","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/j.1440-1681.1991.tb01637.x","volume":"18","author":"M Imaoka","year":"1991","unstructured":"Imaoka M, Morimoto S, Kitano S, Fukuo F, Ogihara T. Calcium metabolism in elderly hypertensive patients: possible participation of exaggerated sodium, calcium and phosphate excretion. Clin Exp Pharmacol Physiol. 1991;18(9):631\u201341.","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"3","key":"285_CR13","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1111\/j.1365-2265.2005.02226.x","volume":"62","author":"L Mosekilde","year":"2005","unstructured":"Mosekilde L. Vitamin D and the elderly. Clin Endocrinol (Oxf). 2005;62(3):265\u201381. doi: 10.1111\/j.1365-2265.2005.02226.x .","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"11","key":"285_CR14","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1001\/jama.292.11.1326","volume":"292","author":"RG Schlienger","year":"2004","unstructured":"Schlienger RG, Kraenzlin ME, Jick SS, Meier CR. Use of beta-blockers and risk of fractures. JAMA. 2004;292(11):1326\u201332. doi: 10.1001\/jama.292.11.1326 .","journal-title":"JAMA"},{"issue":"4","key":"285_CR15","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1111\/j.1365-2796.2006.01695.x","volume":"260","author":"M Wiens","year":"2006","unstructured":"Wiens M, Etminan M, Gill SS, Takkouche B. Effects of antihypertensive drug treatments on fracture outcomes: a meta-analysis of observational studies. J Intern Med. 2006;260(4):350\u201362. doi: 10.1111\/j.1365-2796.2006.01695.x .","journal-title":"J Intern Med"},{"issue":"1","key":"285_CR16","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1002\/jbmr.5650100115","volume":"10","author":"G Jones","year":"1995","unstructured":"Jones G, Nguyen T, Sambrook PN, Eisman JA. Thiazide diuretics and fractures: can meta-analysis help? J Bone Miner Res Off J Am Soc Bone Miner Res. 1995;10(1):106\u201311. doi: 10.1002\/jbmr.5650100115 .","journal-title":"J Bone Miner Res Off J Am Soc Bone Miner Res"},{"issue":"1","key":"285_CR17","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1001\/jamainternmed.2016.6821","volume":"177","author":"R Puttnam","year":"2017","unstructured":"Puttnam R, Davis BR, Pressel SL, et al. Association of 3 different antihypertensive medications with hip and pelvic fracture risk in older adults: secondary analysis of a randomized clinical trial. JAMA Intern Med. 2017;177(1):67\u201376. doi: 10.1001\/jamainternmed.2016.6821 .","journal-title":"JAMA Intern Med"},{"issue":"3","key":"285_CR18","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1152\/physrev.00036.2005","volume":"86","author":"M Paul","year":"2006","unstructured":"Paul M, Poyan Mehr A, Kreutz R. Physiology of local renin-angiotensin systems. Physiol Rev. 2006;86(3):747\u2013803. doi: 10.1152\/physrev.00036.2005 .","journal-title":"Physiol Rev"},{"issue":"6","key":"285_CR19","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1152\/japplphysiol.00182.2010a","volume":"109","author":"LG Navar","year":"2010","unstructured":"Navar LG. Counterpoint: Activation of the intrarenal renin-angiotensin system is the dominant contributor to systemic hypertension. J Appl Physiol. 2010;109(6):1998\u20132000. doi: 10.1152\/japplphysiol.00182.2010a (discussion 15).","journal-title":"J Appl Physiol."},{"issue":"2","key":"285_CR20","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1359\/jbmr.081006","volume":"24","author":"Y Asaba","year":"2009","unstructured":"Asaba Y, Ito M, Fumoto T, et al. Activation of renin-angiotensin system induces osteoporosis independently of hypertension. J Bone Miner Res Off J Am Soc Bone Miner Res. 2009;24(2):241\u201350. doi: 10.1359\/jbmr.081006 .","journal-title":"J Bone Miner Res Off J Am Soc Bone Miner Res"},{"issue":"4","key":"285_CR21","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1210\/jcem.75.4.1400892","volume":"75","author":"FD Grant","year":"1992","unstructured":"Grant FD, Mandel SJ, Brown EM, Williams GH, Seely EW. Interrelationships between the renin-angiotensin-aldosterone and calcium homeostatic systems. J Clin Endocrinol Metab. 1992;75(4):988\u201392. doi: 10.1210\/jcem.75.4.1400892 .","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"285_CR22","doi-asserted-by":"publisher","first-page":"e0122691","DOI":"10.1371\/journal.pone.0122691","volume":"10","author":"S Yamamoto","year":"2015","unstructured":"Yamamoto S, Kido R, Onishi Y, et al. Use of renin-angiotensin system inhibitors is associated with reduction of fracture risk in hemodialysis patients. PLoS ONE. 2015;10(4):e0122691. doi: 10.1371\/journal.pone.0122691 .","journal-title":"PLoS ONE"},{"issue":"4","key":"285_CR23","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.bone.2005.09.011","volume":"38","author":"H Lynn","year":"2006","unstructured":"Lynn H, Kwok T, Wong SY, Woo J, Leung PC. Angiotensin converting enzyme inhibitor use is associated with higher bone mineral density in elderly Chinese. Bone. 2006;38(4):584\u20138. doi: 10.1016\/j.bone.2005.09.011 .","journal-title":"Bone"},{"issue":"3","key":"285_CR24","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1097\/01.hjh.0000203845.26690.cb","volume":"24","author":"L Rejnmark","year":"2006","unstructured":"Rejnmark L, Vestergaard P, Mosekilde L. Treatment with beta-blockers, ACE inhibitors, and calcium-channel blockers is associated with a reduced fracture risk: a nationwide case-control study. J Hypertens. 2006;24(3):581\u20139. doi: 10.1097\/01.hjh.0000203845.26690.cb .","journal-title":"J Hypertens"},{"issue":"22","key":"285_CR25","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1001\/2013.jamainternmed.469","volume":"172","author":"DA Butt","year":"2012","unstructured":"Butt DA, Mamdani M, Austin PC, Tu K, Gomes T, Glazier RH. The risk of hip fracture after initiating antihypertensive drugs in the elderly. Arch Intern Med. 2012;172(22):1739\u201344. doi: 10.1001\/2013.jamainternmed.469 .","journal-title":"Arch Intern Med"},{"issue":"6","key":"285_CR26","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1007\/s00774-012-0363-3","volume":"30","author":"YF Zhang","year":"2012","unstructured":"Zhang YF, Qin L, Leung PC, Kwok TC. The effect of angiotensin-converting enzyme inhibitor use on bone loss in elderly Chinese. J Bone Miner Metab. 2012;30(6):666\u201373. doi: 10.1007\/s00774-012-0363-3 .","journal-title":"J Bone Miner Metab"},{"issue":"3","key":"285_CR27","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1007\/s12020-016-1201-5","volume":"55","author":"YZ Cheng","year":"2017","unstructured":"Cheng YZ, Huang ZZ, Shen ZF, et al. ACE inhibitors and the risk of fractures: a meta-analysis of observational studies. Endocrine. 2017;55(3):732\u201340. doi: 10.1007\/s12020-016-1201-5 .","journal-title":"Endocrine"},{"issue":"24","key":"285_CR28","doi-asserted-by":"publisher","first-page":"2907","DOI":"10.4103\/0366-6999.195472","volume":"129","author":"HY Chen","year":"2016","unstructured":"Chen HY, Ma KY, Hsieh PL, Liou YS, Jong GP. Long-term effects of antihypertensive drug use and new-onset osteoporotic fracture in elderly patients: a population-based longitudinal cohort study. Chin Med J (Engl). 2016;129(24):2907\u201312. doi: 10.4103\/0366-6999.195472 .","journal-title":"Chin Med J (Engl)"},{"key":"285_CR29","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.ijcard.2015.01.072","volume":"184","author":"HJ Choi","year":"2015","unstructured":"Choi HJ, Park C, Lee YK, Ha YC, Jang S, Shin CS. Risk of fractures in subjects with antihypertensive medications: a nationwide claim study. Int J Cardiol. 2015;184:62\u20137. doi: 10.1016\/j.ijcard.2015.01.072 .","journal-title":"Int J Cardiol"},{"issue":"4","key":"285_CR30","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","volume":"61","author":"E Elm von","year":"2008","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol. 2008;61(4):344\u20139. doi: 10.1016\/j.jclinepi.2007.11.008 .","journal-title":"J Clin Epidemiol"},{"issue":"1\u20132","key":"285_CR31","first-page":"46","volume":"20","author":"JT Salonen","year":"1988","unstructured":"Salonen JT. Is there a continuing need for longitudinal epidemiologic research? The Kuopio Ischaemic Heart Disease Risk Factor Study. Ann Clin Res. 1988;20(1\u20132):46\u201350.","journal-title":"Ann Clin Res"},{"key":"285_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2012.12.072","author":"J Karppi","year":"2013","unstructured":"Karppi J, Kurl S, Makikallio TH, Ronkainen K, Laukkanen JA. Serum beta-carotene concentrations and the risk of congestive heart failure in men: a population-based study. Int J Cardiol. 2013;. doi: 10.1016\/j.ijcard.2012.12.072 .","journal-title":"Int J Cardiol"},{"issue":"3","key":"285_CR33","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1161\/01.CIR.86.3.803","volume":"86","author":"JT Salonen","year":"1992","unstructured":"Salonen JT, Nyyssonen K, Korpela H, Tuomilehto J, Seppanen R, Salonen R. High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men. Circulation. 1992;86(3):803\u201311.","journal-title":"Circulation"},{"issue":"11","key":"285_CR34","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1016\/j.amjcard.2009.01.371","volume":"103","author":"JA Laukkanen","year":"2009","unstructured":"Laukkanen JA, Laaksonen D, Lakka TA, et al. Determinants of cardiorespiratory fitness in men aged 42 to 60\u00a0years with and without cardiovascular disease. Am J Cardiol. 2009;103(11):1598\u2013604. doi: 10.1016\/j.amjcard.2009.01.371 .","journal-title":"Am J Cardiol"},{"issue":"5","key":"285_CR35","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1007\/s00125-015-3520-0","volume":"58","author":"SK Kunutsor","year":"2015","unstructured":"Kunutsor SK, Khan H, Laukkanen JA. Serum albumin concentration and incident type 2 diabetes risk: new findings from a population-based cohort study. Diabetologia. 2015;58(5):961\u20137. doi: 10.1007\/s00125-015-3520-0 .","journal-title":"Diabetologia"},{"key":"285_CR36","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4757-3294-8","volume-title":"Modeling survival data: extending the cox model","author":"TM Therneau","year":"2000","unstructured":"Therneau TM, Grambsch PM. Modeling survival data: extending the cox model. New York: Springer; 2000."},{"issue":"7","key":"285_CR37","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","volume":"6","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097. doi: 10.1371\/journal.pmed.1000097 .","journal-title":"PLoS Med"},{"issue":"15","key":"285_CR38","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","volume":"283","author":"DF Stroup","year":"2000","unstructured":"Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology. JAMA J Am Med Assoc. 2000;283(15):2008\u201312. doi: 10.1001\/jama.283.15.2008 .","journal-title":"JAMA J Am Med Assoc"},{"key":"285_CR39","unstructured":"Wells GA, Shea B, O\u2019Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2011. http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp Accessed 20 Aug."},{"key":"285_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(16)30184-3","author":"SK Kunutsor","year":"2017","unstructured":"Kunutsor SK, Seidu S, Khunti K. Statins and primary prevention of venous thromboembolism: a systematic review and meta-analysis. Lancet Haematol. 2017. doi: 10.1016\/S2352-3026(16)30184-3 .","journal-title":"Lancet Haematol"},{"issue":"6","key":"285_CR41","first-page":"1269","volume":"11","author":"J Cornfield","year":"1951","unstructured":"Cornfield J. A method of estimating comparative rates from clinical data; applications to cancer of the lung, breast, and cervix. J Natl Cancer Inst. 1951;11(6):1269\u201375.","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"285_CR42","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","volume":"7","author":"R DerSimonian","year":"1986","unstructured":"DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177\u201388.","journal-title":"Control Clin Trials"},{"issue":"7414","key":"285_CR43","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JP Higgins","year":"2003","unstructured":"Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557\u201360. doi: 10.1136\/bmj.327.7414.557 .","journal-title":"BMJ"},{"issue":"7","key":"285_CR44","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1002\/jbmr.356","volume":"26","author":"DH Solomon","year":"2011","unstructured":"Solomon DH, Mogun H, Garneau K, Fischer MA. Risk of fractures in older adults using antihypertensive medications. J Bone Miner Res Off J Am Soc Bone Miner Res. 2011;26(7):1561\u20137. doi: 10.1002\/jbmr.356 .","journal-title":"J Bone Miner Res Off J Am Soc Bone Miner Res"},{"issue":"6","key":"285_CR45","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1016\/j.bone.2012.08.126","volume":"51","author":"HJ Song","year":"2012","unstructured":"Song HJ, Lee J, Kim Y-J, et al. \u03b21 selectivity of \u03b2-blockers and reduced risk of fractures in elderly hypertension patients. Bone. 2012;51(6):1008\u201315. doi: 10.1016\/j.bone.2012.08.126 .","journal-title":"Bone"},{"key":"285_CR46","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/1471-2318-14-131","volume":"14","author":"K Thorell","year":"2014","unstructured":"Thorell K, Ranstad K, Midlov P, Borgquist L, Halling A. Is use of fall risk-increasing drugs in an elderly population associated with an increased risk of hip fracture, after adjustment for multimorbidity level: a cohort study. BMC Geriatr. 2014;14:131. doi: 10.1186\/1471-2318-14-131 .","journal-title":"BMC Geriatr"},{"key":"285_CR47","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/s12877-015-0154-5","volume":"15","author":"S Ruths","year":"2015","unstructured":"Ruths S, Bakken MS, Ranhoff AH, Hunskaar S, Engesaeter LB, Engeland A. Risk of hip fracture among older people using antihypertensive drugs: a nationwide cohort study. BMC Geriatr. 2015;15:153. doi: 10.1186\/s12877-015-0154-5 .","journal-title":"BMC Geriatr"},{"issue":"12","key":"285_CR48","doi-asserted-by":"publisher","first-page":"e009522","DOI":"10.1136\/bmjopen-2015-009522","volume":"5","author":"M Torstensson","year":"2015","unstructured":"Torstensson M, Hansen AH, Leth-Moller K, et al. Danish register-based study on the association between specific cardiovascular drugs and fragility fractures. BMJ Open. 2015;5(12):e009522. doi: 10.1136\/bmjopen-2015-009522 .","journal-title":"BMJ Open"},{"issue":"11","key":"285_CR49","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1007\/s40266-015-0306-5","volume":"32","author":"G Corrao","year":"2015","unstructured":"Corrao G, Mazzola P, Monzio Compagnoni M, et al. Antihypertensive medications, loop diuretics, and risk of hip fracture in the elderly: a population-based cohort study of 81,617 Italian patients newly treated between 2005 and 2009. Drugs Aging. 2015;32(11):927\u201336. doi: 10.1007\/s40266-015-0306-5 .","journal-title":"Drugs Aging"},{"key":"285_CR50","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/afw150","author":"T Kwok","year":"2016","unstructured":"Kwok T, Leung J, Barrett-Connor E. Osteoporotic fractures in men research G. ARB users exhibit a lower fracture incidence than ACE inhibitor users among older hypertensive men. Age Ageing. 2016;. doi: 10.1093\/ageing\/afw150 .","journal-title":"Age Ageing"},{"issue":"3 Pt 2","key":"285_CR51","first-page":"F546","volume":"253","author":"DH Ellison","year":"1987","unstructured":"Ellison DH, Velazquez H, Wright FS. Thiazide-sensitive sodium chloride cotransport in early distal tubule. Am J Physiol. 1987;253(3 Pt 2):F546\u201354.","journal-title":"Am J Physiol"},{"issue":"1 Pt 1","key":"285_CR52","doi-asserted-by":"crossref","first-page":"C109","DOI":"10.1152\/ajpcell.1997.272.1.C109","volume":"272","author":"EL Barry","year":"1997","unstructured":"Barry EL, Gesek FA, Kaplan MR, Hebert SC, Friedman PA. Expression of the sodium-chloride cotransporter in osteoblast-like cells: effect of thiazide diuretics. Am J Physiol. 1997;272(1 Pt 1):C109\u201316.","journal-title":"Am J Physiol"},{"issue":"5","key":"285_CR53","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S8756-3282(99)00211-2","volume":"25","author":"M Cherruau","year":"1999","unstructured":"Cherruau M, Facchinetti P, Baroukh B, Saffar JL. Chemical sympathectomy impairs bone resorption in rats: a role for the sympathetic system on bone metabolism. Bone. 1999;25(5):545\u201351.","journal-title":"Bone"},{"issue":"2","key":"285_CR54","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1002\/jemt.10121","volume":"58","author":"A Togari","year":"2002","unstructured":"Togari A. Adrenergic regulation of bone metabolism: possible involvement of sympathetic innervation of osteoblastic and osteoclastic cells. Microsc Res Tech. 2002;58(2):77\u201384. doi: 10.1002\/jemt.10121 .","journal-title":"Microsc Res Tech"},{"issue":"6","key":"285_CR55","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1210\/en.2003-0150","volume":"144","author":"JL Lavoie","year":"2003","unstructured":"Lavoie JL, Sigmund CD. Minireview: overview of the renin-angiotensin system\u2014an endocrine and paracrine system. Endocrinology. 2003;144(6):2179\u201383. doi: 10.1210\/en.2003-0150 .","journal-title":"Endocrinology"},{"issue":"11","key":"285_CR56","doi-asserted-by":"publisher","first-page":"2236","DOI":"10.1097\/HJH.0b013e32834bbb4d","volume":"29","author":"S Inaba","year":"2011","unstructured":"Inaba S, Iwai M, Furuno M, et al. Role of angiotensin-converting enzyme 2 in cardiac hypertrophy induced by nitric oxide synthase inhibition. J Hypertens. 2011;29(11):2236\u201345. doi: 10.1097\/HJH.0b013e32834bbb4d .","journal-title":"J Hypertens"},{"issue":"2","key":"285_CR57","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1007\/s00125-003-1295-1","volume":"47","author":"T Lau","year":"2004","unstructured":"Lau T, Carlsson PO, Leung PS. Evidence for a local angiotensin-generating system and dose-dependent inhibition of glucose-stimulated insulin release by angiotensin II in isolated pancreatic islets. Diabetologia. 2004;47(2):240\u20138. doi: 10.1007\/s00125-003-1295-1 .","journal-title":"Diabetologia"},{"issue":"8","key":"285_CR58","doi-asserted-by":"publisher","first-page":"4857","DOI":"10.1074\/jbc.M807610200","volume":"284","author":"Y Izu","year":"2009","unstructured":"Izu Y, Mizoguchi F, Kawamata A, et al. Angiotensin II type 2 receptor blockade increases bone mass. J Biol Chem. 2009;284(8):4857\u201364. doi: 10.1074\/jbc.M807610200 .","journal-title":"J Biol Chem"},{"issue":"1","key":"285_CR59","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1677\/joe.0.1520005","volume":"152","author":"R Hatton","year":"1997","unstructured":"Hatton R, Stimpel M, Chambers TJ. Angiotensin II is generated from angiotensin I by bone cells and stimulates osteoclastic bone resorption in vitro. J Endocrinol. 1997;152(1):5\u201310.","journal-title":"J Endocrinol"},{"issue":"1","key":"285_CR60","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1006\/bbrc.1996.5914","volume":"230","author":"Y Hiruma","year":"1997","unstructured":"Hiruma Y, Inoue A, Hirose S, Hagiwara H. Angiotensin II stimulates the proliferation of osteoblast-rich populations of cells from rat calvariae. Biochem Biophys Res Commun. 1997;230(1):176\u20138. doi: 10.1006\/bbrc.1996.5914 .","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"285_CR61","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1002\/(SICI)1097-4652(199804)175:1<89::AID-JCP10>3.0.CO;2-J","volume":"175","author":"S Lamparter","year":"1998","unstructured":"Lamparter S, Kling L, Schrader M, Ziegler R, Pfeilschifter J. Effects of angiotensin II on bone cells in vitro. J Cell Physiol. 1998;175(1):89\u201398. doi: 10.1002\/(SICI)1097-4652(199804)175:1<89:AID-JCP10>3.0.CO;2-J .","journal-title":"J Cell Physiol"},{"issue":"1","key":"285_CR62","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s00467-003-1361-4","volume":"19","author":"SJ Schurman","year":"2004","unstructured":"Schurman SJ, Bergstrom WH, Shoemaker LR, Welch TR. Angiotensin II reduces calcium uptake into bone. Pediatr Nephrol. 2004;19(1):33\u20135. doi: 10.1007\/s00467-003-1361-4 .","journal-title":"Pediatr Nephrol"},{"issue":"3","key":"285_CR63","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1677\/joe.0.1560543","volume":"156","author":"H Hagiwara","year":"1998","unstructured":"Hagiwara H, Hiruma Y, Inoue A, Yamaguchi A, Hirose S. Deceleration by angiotensin II of the differentiation and bone formation of rat calvarial osteoblastic cells. J Endocrinol. 1998;156(3):543\u201350.","journal-title":"J Endocrinol"},{"issue":"7","key":"285_CR64","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1096\/fj.07-098954","volume":"22","author":"H Shimizu","year":"2008","unstructured":"Shimizu H, Nakagami H, Osako MK, et al. Angiotensin II accelerates osteoporosis by activating osteoclasts. FASEB J Off Publ Fed Am Soc Exp Biol. 2008;22(7):2465\u201375. doi: 10.1096\/fj.07-098954 .","journal-title":"FASEB J Off Publ Fed Am Soc Exp Biol"},{"issue":"4","key":"285_CR65","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/S1734-1140(12)70882-4","volume":"64","author":"BO Donmez","year":"2012","unstructured":"Donmez BO, Ozdemir S, Sarikanat M, et al. Effect of angiotensin II type 1 receptor blocker on osteoporotic rat femurs. Pharmacol Rep. 2012;64(4):878\u201388.","journal-title":"Pharmacol Rep"},{"issue":"8","key":"285_CR66","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1111\/j.1476-5381.2010.00651.x","volume":"159","author":"P Garcia","year":"2010","unstructured":"Garcia P, Schwenzer S, Slotta JE, et al. Inhibition of angiotensin-converting enzyme stimulates fracture healing and periosteal callus formation\u2014role of a local renin-angiotensin system. Br J Pharmacol. 2010;159(8):1672\u201380. doi: 10.1111\/j.1476-5381.2010.00651.x .","journal-title":"Br J Pharmacol"},{"issue":"4","key":"285_CR67","doi-asserted-by":"crossref","first-page":"E164","DOI":"10.25011\/cim.v38i4.24261","volume":"38","author":"A Bayar","year":"2015","unstructured":"Bayar A, Turan A, Gulle K, Akpolat M, Turan I, Turhan E. The effects of the angiotensin converting enzyme inhibitor enalapril and the angiotensin II type 1 receptor blocker Losartan on fracture healing in rats. Clin Invest Med. 2015;38(4):E164\u201372.","journal-title":"Clin Invest Med"}],"container-title":["European Journal of Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10654-017-0285-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10654-017-0285-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10654-017-0285-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T13:43:53Z","timestamp":1569937433000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10654-017-0285-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,27]]},"references-count":67,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["285"],"URL":"https:\/\/doi.org\/10.1007\/s10654-017-0285-4","relation":{},"ISSN":["0393-2990","1573-7284"],"issn-type":[{"value":"0393-2990","type":"print"},{"value":"1573-7284","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,27]]}}}